Torrent site passes FDA

Torrent Pharmaceuticals’ Bileshwarapura oncology facility passed a US FDA inspection with zero observations and was cleared to supply the US market. The inspection result was posted as confirmation of the site's regulatory compliance for manufacturing operations. (x.com)

Get your own daily briefing

Scout delivers personalized news, insights, and conversations tailored to your role and industry.

Download on the App Store

Shared from Scout - Be the smartest in the room.